Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 337

1.

Health Care Human Factors/Ergonomics Fieldwork in Home and Community Settings.

Valdez RS, Holden RJ.

Ergon Des. 2016 Oct;24(4):4-9. doi: 10.1177/1064804615622111. Epub 2016 Aug 16.

2.

Genotypic diversity and phenotypic traits of Streptococcus mutans isolates and their relation to severity of early childhood caries.

Valdez RMA, Duque C, Caiaffa KS, Dos Santos VR, Loesch MLA, Colombo NH, Arthur RA, Negrini TC, Boriollo MFG, Delbem ACB.

BMC Oral Health. 2017 Jul 14;17(1):115. doi: 10.1186/s12903-017-0406-1.

3.

Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy.

Kim S, Zhu Y, Romitti PA, Fox DJ, Sheehan DW, Valdez R, Matthews D, Barber BJ; MD STARnet.

Neuromuscul Disord. 2017 Aug;27(8):730-737. doi: 10.1016/j.nmd.2017.05.019. Epub 2017 Jun 5.

PMID:
28645460
4.

Switch from agalsidase beta to agalsidase alfa in the enzyme replacement therapy of patients with Fabry disease in Latin America.

Ripeau D, Amartino H, Cedrolla M, Urtiaga L, Urdaneta B, Cano M, Valdez R, Antongiovanni N, Masllorens F.

Medicina (B Aires). 2017;77(3):173-179.

5.

Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic-ischemic encephalopathy.

Sampath D, Valdez R, White AM, Raol YH.

Neuropharmacology. 2017 Sep 1;123:126-135. doi: 10.1016/j.neuropharm.2017.06.002. Epub 2017 Jun 3.

PMID:
28587899
6.

Extreme hydrothermal conditions at an active plate-bounding fault.

Sutherland R, Townend J, Toy V, Upton P, Coussens J, Allen M, Baratin LM, Barth N, Becroft L, Boese C, Boles A, Boulton C, Broderick NGR, Janku-Capova L, Carpenter BM, Célérier B, Chamberlain C, Cooper A, Coutts A, Cox S, Craw L, Doan ML, Eccles J, Faulkner D, Grieve J, Grochowski J, Gulley A, Hartog A, Howarth J, Jacobs K, Jeppson T, Kato N, Keys S, Kirilova M, Kometani Y, Langridge R, Lin W, Little T, Lukacs A, Mallyon D, Mariani E, Massiot C, Mathewson L, Melosh B, Menzies C, Moore J, Morales L, Morgan C, Mori H, Niemeijer A, Nishikawa O, Prior D, Sauer K, Savage M, Schleicher A, Schmitt DR, Shigematsu N, Taylor-Offord S, Teagle D, Tobin H, Valdez R, Weaver K, Wiersberg T, Williams J, Woodman N, Zimmer M.

Nature. 2017 Jun 1;546(7656):137-140. doi: 10.1038/nature22355. Epub 2017 May 17.

7.

Capture-recapture methodology to study rare conditions using surveillance data for fragile X syndrome and muscular dystrophy.

Smith MG, Royer J, Mann J, McDermott S, Valdez R.

Orphanet J Rare Dis. 2017 Apr 21;12(1):76. doi: 10.1186/s13023-017-0628-y.

8.

Qualitative ergonomics/human factors research in health care: Current state and future directions.

Valdez RS, McGuire KM, Rivera AJ.

Appl Ergon. 2017 Jul;62:43-71. doi: 10.1016/j.apergo.2017.01.016. Epub 2017 Feb 27. Review.

PMID:
28411739
9.

The Impact of Frequency and Tone of Parent-Youth Communication on Type 1 Diabetes Management.

DeBoer MD, Valdez R, Chernavvsky DR, Grover M, Burt Solorzano C, Herbert K, Patek S.

Diabetes Ther. 2017 Jun;8(3):625-636. doi: 10.1007/s13300-017-0259-2. Epub 2017 Apr 12.

10.

Food Insecurity, CKD, and Subsequent ESRD in US Adults.

Banerjee T, Crews DC, Wesson DE, Dharmarajan S, Saran R, Ríos Burrows N, Saydah S, Powe NR; CDC CKD Surveillance Team.

Am J Kidney Dis. 2017 Jul;70(1):38-47. doi: 10.1053/j.ajkd.2016.10.035. Epub 2017 Feb 16.

PMID:
28215947
11.

PhenX measures for phenotyping rare genetic conditions.

Phillips M, Grant T, Giampietro P, Bodurtha J, Valdez R, Maiese DR, Hendershot T, Terry SF, Hamilton CM.

Genet Med. 2017 Jul;19(7):834-837. doi: 10.1038/gim.2016.199. Epub 2017 Jan 12.

12.

From loquacious to reticent: understanding patient health information communication to guide consumer health IT design.

Valdez RS, Guterbock TM, Fitzgibbon K, Williams IC, Wellbeloved-Stone CA, Bears JE, Menefee HK.

J Am Med Inform Assoc. 2017 Jan 9. pii: ocw155. doi: 10.1093/jamia/ocw155. [Epub ahead of print]

PMID:
28069667
13.

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers.

Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, Ritacca NR, McCullough AE, Barrett MT, Hunt KS, Champion MD, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, McWilliams RR, Lazaridis KN, Ramanathan RK, Baker A, Aldrich J, Kurdoglu A, Izatt T, Christoforides A, Cherni I, Nasser S, Reiman R, Cuyugan L, McDonald J, Adkins J, Mastrian SD, Valdez R, Jaroszewski DE, Von Hoff DD, Craig DW, Stewart AK, Carpten JD, Bryce AH.

Sci Rep. 2016 Dec 23;6(1):25. doi: 10.1038/s41598-016-0021-4.

14.

The need for a next-generation public health response to rare diseases.

Valdez R, Grosse SD, Khoury MJ.

Genet Med. 2016 Oct 27. doi: 10.1038/gim.2016.166. [Epub ahead of print]

PMID:
27787501
15.

Corrigendum: The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size.

Planas-Paz L, Orsini V, Boulter L, Calabrese D, Pikiolek M, Nigsch F, Xie Y, Roma G, Donovan A, Marti P, Beckmann N, Dill MT, Carbone W, Bergling S, Isken A, Mueller M, Kinzel B, Yang Y, Mao X, Nicholson TB, Zamponi R, Capodieci P, Valdez R, Rivera D, Loew A, Ukomadu C, Terracciano LM, Bouwmeester T, Cong F, Heim MH, Forbes SJ, Ruffner H, Tchorz JS.

Nat Cell Biol. 2016 Oct 27;18(11):1260. doi: 10.1038/ncb3428. No abstract available.

PMID:
27784900
16.

Testing the Feasibility of a Passive and Active Case Ascertainment System for Multiple Rare Conditions Simultaneously: The Experience in Three US States.

Reichard A, McDermott S, Ruttenber M, Mann J, Smith MG, Royer J, Valdez R.

JMIR Public Health Surveill. 2016 Aug 29;2(2):e151. doi: 10.2196/publichealth.5516.

17.

Mechanisms of Communicating Health Information Through Facebook: Implications for Consumer Health Information Technology Design.

Menefee HK, Thompson MJ, Guterbock TM, Williams IC, Valdez RS.

J Med Internet Res. 2016 Aug 11;18(8):e218. doi: 10.2196/jmir.5949.

18.

Spanish-Language Consumer Health Information Technology Interventions: A Systematic Review.

Chaet AV, Morshedi B, Wells KJ, Barnes LE, Valdez R.

J Med Internet Res. 2016 Aug 10;18(8):e214. doi: 10.2196/jmir.5794.

19.

Comparative in vitro investigation of the cariogenic potential of bifidobacteria.

Valdez RM, Dos Santos VR, Caiaffa KS, Danelon M, Arthur RA, Negrini TC, Delbem AC, Duque C.

Arch Oral Biol. 2016 Nov;71:97-103. doi: 10.1016/j.archoralbio.2016.07.005. Epub 2016 Jul 22.

PMID:
27475723
20.

Evaluation of the utility of popliteal lymph node examination in a cyclophosphamide model of immunotoxicity in the rat.

Lapointe JM, Valdez RA, Ryan AM, Haley PJ.

J Immunotoxicol. 2016 Jul;13(4):449-52. doi: 10.3109/1547691X.2015.1122117. Epub 2016 May 23.

PMID:
27216540

Supplemental Content

Loading ...
Support Center